Dr. Pamela Kunz On The Effectiveness Of Immunotherapies And Their Promising Future

Dr. Pamela Kunz on the Effectiveness of Immunotherapies and Their Promising Future

Targeted Oncology

What About Immunotherapy, Pam Kunz, Stanford University

Dr. Kunz on Potential of Immunotherapy in Neuroendocrine Tumors

"Understanding the Latest NET Clinical Trials" Dr. Pamela Kunz • 2024 #LACNETS Patient Conference

Dr. Kunz on Classifying and Predicting Response in NETs

Targeted Oncology

Can Immunotherapy Be Used for Neuroendocrine Tumors?

Rare Disease Report

Dr. Kunz on Treatment Options for Pancreatic NETs

Dr. Pamela Kunz

Caring4Carcinoid

Targeted Therapies in Pancreatic Neuroendocrine Tumors

Dr. Kunz on the Impact of Lanreotide’s Approval for Neuroendocrine Tumors

Introduction to Neuroendocrine Tumors. Pamela Kunz, MD, Stanford

LACNETS Webinar: "What's New with NETs?" with Pamela Kunz, MD of Yale Cancer Center

CAPPTEM Chemo - Pamela Kunz

LACNETS (14) - Immunotherapy: Does it work for NETs? - Dr. Kunz - 2016 LA NET Patient Ed Conference

The Latest in Systemic Treatments & Considerations for Treatment Sequencing • Dr. Kunz • LACNETS

Dr. Kunz on Sequencing Agents for the Treatment of Pancreatic NETs

Targeted Oncology

Clinical Trials What are They and Who Should Enroll, Pam Kunz, MD, Stanford University

Luncheon with the Experts: Pamela Kunz, MD

Carcinoid Cancer Foundation

NET Primer; Pamela Kunz, MD, Stanford University

The Future of Cancer Immunotherapy: Combination Treatments

GRACE - Global Resource for Advancing Cancer Education